Amneal Pharmaceuticals, Inc. — All Filings
642 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
144/A
15-12G
25
25-NSE
3
4
4/A
424B3
424B7
5
8-A12B
8-K
8-K/A
8-K12B
CERT
CORRESP
DEF 14A
DEF 14C
DEFA14A
EFFECT
POS AM
POSASR
PRE 14A
PRE 14C
RW
S-1
S-1/A
S-3ASR
S-4
S-4/A
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4/A | FORM 4/A | 0001628280-26-021746 | Mar 27, 2026 | Mar 2, 2026 |
| 4/A | FORM 4/A | 0001628280-26-021742 | Mar 27, 2026 | Mar 2, 2026 |
| SCHEDULE 13D/A | — | 0000898432-26-000204 | Mar 26, 2026 | — |
| SCHEDULE 13G/A | — | 0000102909-26-000639 | Mar 26, 2026 | — |
| DEFA14A | DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS | 0001308179-26-000144 | Mar 25, 2026 | — |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001308179-26-000143 | Mar 25, 2026 | May 6, 2026 |
| 4 | FORM 4 | 0001628280-26-015285 | Mar 5, 2026 | Mar 3, 2026 |
| 4 | FORM 4 | 0001628280-26-015283 | Mar 5, 2026 | Mar 3, 2026 |
| 4 | FORM 4 | 0001628280-26-015241 | Mar 5, 2026 | Mar 3, 2026 |
| 4 | FORM 4 | 0001628280-26-015239 | Mar 5, 2026 | Mar 3, 2026 |
| 4 | FORM 4 | 0001628280-26-015238 | Mar 5, 2026 | Mar 3, 2026 |
| 4 | FORM 4 | 0001628280-26-015235 | Mar 5, 2026 | Mar 3, 2026 |
| 4 | FORM 4 | 0001628280-26-013900 | Mar 3, 2026 | Mar 2, 2026 |
| 4 | FORM 4 | 0001628280-26-013893 | Mar 3, 2026 | Mar 2, 2026 |
| 4 | FORM 4 | 0001628280-26-013890 | Mar 3, 2026 | Mar 2, 2026 |
| 4 | FORM 4 | 0001628280-26-013887 | Mar 3, 2026 | Mar 2, 2026 |
| 4 | FORM 4 | 0001628280-26-013882 | Mar 3, 2026 | Mar 2, 2026 |
| 4 | FORM 4 | 0001628280-26-013878 | Mar 3, 2026 | Mar 2, 2026 |
| 10-K | 10-K | 0001723128-26-000011 | Feb 27, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001723128-26-000008 | Feb 27, 2026 | — |
| 8-K | 8-K | 0001628280-26-004738 | Feb 3, 2026 | Feb 2, 2026 |
| 8-K | 8-K | 0001628280-26-003842 | Jan 28, 2026 | Jan 23, 2026 |
| 8-K | 8-K | 0001723128-26-000003 | Jan 13, 2026 | — |
| 4 | FORM 4 | 0001628280-25-053188 | Nov 19, 2025 | Nov 17, 2025 |
| 144 | — | 0001949846-25-000603 | Nov 17, 2025 | — |
| 4 | FORM 4 | 0001628280-25-052413 | Nov 14, 2025 | Nov 12, 2025 |
| 144 | — | 0001628280-25-051697 | Nov 12, 2025 | — |
| 10-Q | 10-Q | 0001723128-25-000062 | Nov 6, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001723128-25-000059 | Oct 30, 2025 | — |
| SCHEDULE 13D/A | — | 0000898432-25-000809 | Oct 7, 2025 | — |
| SCHEDULE 13D/A | — | 0000898432-25-000785 | Oct 6, 2025 | — |
| 4 | FORM 4 | 0001781149-25-000006 | Aug 28, 2025 | Aug 27, 2025 |
| 144 | — | 0002007317-25-000975 | Aug 27, 2025 | — |
| 4 | FORM 4 | 0001738061-25-000004 | Aug 25, 2025 | Aug 22, 2025 |
| 4 | FORM 4 | 0001628280-25-041033 | Aug 22, 2025 | Aug 20, 2025 |
| 144 | — | 0002007317-25-000949 | Aug 22, 2025 | — |
| 144 | — | 0001949846-25-000405 | Aug 22, 2025 | — |
| 144 | — | 0002007317-25-000917 | Aug 20, 2025 | — |
| 144 | — | 0001949846-25-000393 | Aug 20, 2025 | — |
| 4 | FORM 4 | 0001723128-25-000052 | Aug 15, 2025 | Aug 14, 2025 |
| 4 | FORM 4 | 0001723128-25-000051 | Aug 15, 2025 | Aug 13, 2025 |
| 144 | — | 0001949846-25-000378 | Aug 15, 2025 | — |
| 144 | — | 0002007317-25-000875 | Aug 14, 2025 | — |
| 4 | FORM 4 | 0001723128-25-000050 | Aug 13, 2025 | Aug 12, 2025 |
| 4 | FORM 4 | 0001723128-25-000049 | Aug 13, 2025 | Aug 12, 2025 |
| 4 | FORM 4 | 0001723128-25-000048 | Aug 13, 2025 | Aug 12, 2025 |
| 144 | — | 0001949846-25-000368 | Aug 13, 2025 | — |
| 144 | — | 0001949846-25-000362 | Aug 13, 2025 | — |
| 144 | — | 0001949846-25-000361 | Aug 12, 2025 | — |
| 144 | — | 0002007317-25-000849 | Aug 12, 2025 | — |